UBE2N as a novel prognostic and therapeutic biomarker of lung adenocarcinoma

UBE2N as a novel prognostic and therapeutic biomarker of lung adenocarcinoma

BackgroundLung adenocarcinoma (LUAD) represents a significant global health burden. The absence of reliable biomarkers and the heterogeneity in treatment responses continue to hinder improvements in patient prognosis. This study aimed to identify novel biomarkers capable of predicting patient outcom...

Full description

Saved in:
Bibliographic Details
Main Authors: Haofeng Yin, Yibo Xue, Chen Wang, Yanqin Wu, Yuchen Guo, Chunzhen Li, Yunyan Zhang, Shulei Yin, Tiejun Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Immunology
Subjects:
lung adenocarcinoma
UBE2N
prognosis
biomarker
immunotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1636503/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items